1. Home
  2. INCY vs SFM Comparison

INCY vs SFM Comparison

Compare INCY & SFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INCY
  • SFM
  • Stock Information
  • Founded
  • INCY 1991
  • SFM 2002
  • Country
  • INCY United States
  • SFM United States
  • Employees
  • INCY N/A
  • SFM N/A
  • Industry
  • INCY Biotechnology: Commercial Physical & Biological Resarch
  • SFM Food Chains
  • Sector
  • INCY Health Care
  • SFM Consumer Staples
  • Exchange
  • INCY Nasdaq
  • SFM Nasdaq
  • Market Cap
  • INCY 13.0B
  • SFM 14.4B
  • IPO Year
  • INCY 1993
  • SFM 2013
  • Fundamental
  • Price
  • INCY $86.64
  • SFM $138.83
  • Analyst Decision
  • INCY Buy
  • SFM Buy
  • Analyst Count
  • INCY 20
  • SFM 15
  • Target Price
  • INCY $80.31
  • SFM $168.20
  • AVG Volume (30 Days)
  • INCY 1.7M
  • SFM 1.6M
  • Earning Date
  • INCY 10-28-2025
  • SFM 10-29-2025
  • Dividend Yield
  • INCY N/A
  • SFM N/A
  • EPS Growth
  • INCY 900.04
  • SFM 52.36
  • EPS
  • INCY 4.37
  • SFM 4.84
  • Revenue
  • INCY $4,584,996,000.00
  • SFM $8,399,001,000.00
  • Revenue This Year
  • INCY $16.26
  • SFM $16.58
  • Revenue Next Year
  • INCY $11.07
  • SFM $11.30
  • P/E Ratio
  • INCY $19.84
  • SFM $28.67
  • Revenue Growth
  • INCY 18.87
  • SFM 16.83
  • 52 Week Low
  • INCY $53.56
  • SFM $97.61
  • 52 Week High
  • INCY $87.99
  • SFM $182.00
  • Technical
  • Relative Strength Index (RSI)
  • INCY 64.89
  • SFM 32.84
  • Support Level
  • INCY $83.41
  • SFM $136.33
  • Resistance Level
  • INCY $87.99
  • SFM $152.25
  • Average True Range (ATR)
  • INCY 1.68
  • SFM 3.01
  • MACD
  • INCY -0.37
  • SFM -0.21
  • Stochastic Oscillator
  • INCY 70.52
  • SFM 15.70

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About SFM Sprouts Farmers Market Inc.

Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.

Share on Social Networks: